Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2019 / NGS technology: Trends and clinical applications

NGS technology: Trends and clinical applications

06/04/2019

Share

DNA sequencing using next-generation technologies has become established in several clinical areas over the past decade and is rapidly gaining popularity in many others. Reproductive health, oncology, Mendelian diseases, complex diseases, and infectious diseases are key areas where next-generation sequencing (NGS) has a significant presence or is expected to establish itself in the coming years.

As the Human Genome Project was coming to an end in 2003—two years ahead of schedule—new technological developments sparked a second revolution in the study of genomes. These so-called nextgeneration sequencing (NGS) techniques use massively parallel sequencing to decode large areas of the genome, orders of magnitude faster than Sanger sequencing, which had been key to the success of the Human Genome Project (1).

NGS technologies developed in the decade that followed fall into two categories: those that use clonal amplification (sometimes known as second-generation sequencing) and single-molecule techniques (third generation). These innovations helped drive down the cost per nucleotide to the extent that it opened up NGS to a wide range of clinical applications.

>> Download the full Application Note as PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Oncomine Dx Target Test – an IVD NGS solution for every lab

February 20, 2019

What to Consider When Choosing a Microscope Camera

March 5, 2019

Comparison of cfDNA Reference Material Prepared using Enzymatic Fragmentation or Sonication for the Validation of Liquid Biopsy Assays

May 28, 2019

Rapid, High-Performance Tumor Profiling Using CleanPlex® OncoZoom® Cancer Hotspot Panel and SOPHiA™ AI

April 18, 2019

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.